Current Report Filing (8-k)
November 03 2022 - 07:05AM
Edgar (US Regulatory)
0001682852false00016828522022-11-032022-11-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 3,
2022
MODERNA, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware |
|
001-38753 |
|
81-3467528 |
|
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
|
|
|
200 Technology Square |
|
|
|
Cambridge, MA
|
|
02139 |
|
(Address of principal executive offices) |
|
(Zip code) |
Registrant’s telephone number, including area code:
(617) 714-6500
Not Applicable
(Former name or former address, if changed since last
report.)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
|
|
|
|
|
|
|
☐ |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
|
|
|
|
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
|
|
|
|
|
|
|
☐ |
Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act
(17CFR 240.14d-2(b)) |
|
|
|
|
|
|
|
☐ |
Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class |
|
Trading symbol(s) |
|
Name of each exchange on which registered |
|
Common stock, par value $0.0001 per share |
|
MRNA |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 or
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 2.02 Results of Operations and Financial
Condition.
On November 3, 2022, Moderna, Inc. issued a press release
announcing its financial results for the third quarter ended
September 30, 2022. A copy of the press release is furnished as
Exhibit 99.1 and is incorporated herein by reference.
The information in this Current Report on Form 8-K, including
Exhibit 99.1 attached hereto, is intended to be furnished and shall
not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as expressly set
forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
|
|
|
|
|
|
|
Exhibit |
|
|
|
No. |
|
Description |
|
|
|
|
99.1 |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL
document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
MODERNA, INC.
|
|
|
|
|
Date: November 3, 2022
|
By: |
/s/ James M. Mock |
|
|
|
|
|
James M. Mock |
|
|
Chief Financial Officer |
|
|
|
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Dec 2022 to Jan 2023
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jan 2022 to Jan 2023
